217 results on '"Morgan, Jennifer E."'
Search Results
2. Myogenic Cell Proliferation and Generation of a Reversible Tumorigenic Phenotype Are Triggered by Preirradiation of the Recipient Site
3. Antisense-Induced Exon Skipping and Synthesis of Dystrophin in the mdx Mouse
4. Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell-like Properties as the Myogenic Source
5. Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models
6. Satellite cells from dystrophic muscle retain regenerative capacity
7. Publisher Correction: Necroptosis mediates myofibre death in dystrophin-deficient mice
8. Necroptosis mediates myofibre death in dystrophin-deficient mice
9. Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
10. Lentiviral vectors can be used for full-length dystrophin gene therapy
11. Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy
12. Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles
13. Normal Myogenic Cells from Newborn Mice Restore Normal Histology to Degenerating Muscles of the mdx Mouse
14. Dystrophin involvement in peripheral circadian SRF signalling
15. CORRESPONDENCE: Measuring dystrophin—faster is not necessarily better
16. The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy
17. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche
18. Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements
19. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover
20. Recent progress in satellite cell/myoblast engraftment – relevance for therapy
21. The human desmin locus: Gene organization and LCR-mediated transcriptional control
22. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials
23. Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells
24. Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
25. Dual regulation of the AMP‐activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle
26. Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart
27. A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples
28. Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation
29. Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment
30. Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapy
31. Delivery of large transgene cassettes by foamy virus vector
32. The effect of calorie restriction on mouse skeletal muscle is sex, strain and time-dependent
33. Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation
34. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies
35. Whole exome sequencing in patients with congenital myopathy
36. Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy
37. Loss-of-function mutations inSCN4Acause severe foetal hypokinesia or ‘classical’ congenital myopathy
38. 527. Exploiting Retroviral Recombination for the Delivery of Full-Length Dystrophin cDNA
39. The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells
40. Multiple Insights from Myogenic Cell Transplants
41. Mouse Regenerating Myofibers Detected as False-Positive Donor Myofibers with Anti-Human Spectrin
42. Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy
43. Grafting of a Single Donor Myofibre Promotes Hypertrophy in Dystrophic Mouse Muscle
44. Defects in Glycosylation Impair Satellite Stem Cell Function and Niche Composition in the Muscles of the Dystrophic Large myd Mouse
45. Donor Satellite Cell Engraftment Is SignificantlyAugmented When the Host Niche Is Preserved and Endogenous Satellite Cells Are Incapacitated
46. Measuring dystrophin—faster is not necessarily better
47. Human satellite cells: identification on human muscle fibres
48. Restoration of dystrophin expression using the Sleeping Beauty transposon
49. A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies
50. Contribution of Human Muscle-Derived Cells to Skeletal Muscle Regeneration in Dystrophic Host Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.